2. Disease Areas
  3. Urogenital Disease

Urogenital Disease

Urogenital tract diseases encompass disorders of the lower urinary system and related structures, often arising from neurological impairment, resulting in conditions such as neurogenic bladder dysfunction, urinary incontinence, and recurrent urinary tract infections.

 

Urogenital Disease (1):

Cat. No. Product Name CAS No. Purity Chemical Structure
  • HY-17386
    Rosiglitazone 122320-73-4 99.94%
    Rosiglitazone (BRL 49653) is an orally active selective PPARγ agonist (EC50: 60 nM, Kd: 40 nM). Rosiglitazone is an TRPC5 activator (EC50: 30 μM) and TRPM3 inhibitor. Rosiglitazone can be used in the research of obesity and diabetes, senescence, ovarian cancer.
    Rosiglitazone